Article
The surgical resection of the primary tumor increases survival in patients with EGFR-mutant advanced non-small cell lung cancer: a tertiary center cohort study.
Scientific reports - 29 Dec 2022
Chen Ying-Yuan, Su Po-Lan, Huang Wei-Li, Chang Chao-Chun, Yen Yi-Ting, Lin Chien-Chung, Tseng Yau-Lin
Abstract excerpt
Tumor resection could increase treatment efficacy of epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKI) in patients with advanced EGFR-mutant non-small cell lung cancer (NSCLC). This study aimed to retrospectively analyze patients with advanced EGFR-mutant NSCLC from a Taiwanese tertiary center and receiving EGFR-TKI treatment with or without tumor resection. A total of 349 patients were...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
